A Phase 2 Study of Epcoritamab and Rituximab for first-line treatment of follicular lymphoma

ENROLLING

877-DF-TRIAL (877-338-7425)

Trial ID:

NCT05783609

View Complete trial on ClinicalTrials.gov

Protocol # :

22-702

Phase

II

Disease Sites

Non-Hodgkin's Lymphoma

Principal Investigator

Merryman, Reid, W

Site Research Nurses

Aspinwall, Sheridan

Brennan, Lisa

Bresnahan, Caitlin

Chung, Anita

Kats, Vanessa

Kilcommons, Marykate

Normilus, Samantha

Patterson, Victoria

Re, Sandra

Trial Description

Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-702

22-702